Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

The Channel

  1. Week in review: How Trump's policies...

    22 minutes ago
    The Fly
  2. After Decades Of Denials, Pentagon...

    about 9 hours ago
    Silver Doctors
  3. Greg Hunter: President Trump Has...

    about 11 hours ago
    Silver Doctors
  4. Cartel Is VERY NERVOUS Right Now, We...

    about 13 hours ago
    Silver Doctors
  5. Oil Prices Down Year-over-year

    about 14 hours ago
    Calculated Risk
  6. Betterment Review: The Original...

    about 14 hours ago
    Bible Money Matters
  7. SGTreport: President Trump Vs The Deep...

    about 14 hours ago
    Silver Doctors
  8. Eric Sprott: Recession is coming. Are...

    about 16 hours ago
    Silver Doctors

Trade Idea of the Day Presented by: The Fly

Texas Roadhouse, Chipotle pullbacks an opportunity to buy, says Baird

Baird analyst David Tarantino said he would be a buyer of shares of Texas Roadhouse (TXRH) and Chipotle (CMG) amid today's weakness, which he attributes to concerns about the potential for rising protein prices tied to the African swine fever outbreak in China. While a rise in certain protein... Read More

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Avon Products (AVP) downgraded to Neutral from Buy at DA Davidson. 2. SQM (SQM) downgraded to Market Perform from Outperform at BMO Capital with analyst Joel Jackson saying a lithium rebound or a bottoming in sentiment may take longer and that the company's earnings trajectory no longer warrants a bullish outlook. 3. Lennox (LII) downgraded to Sell from Neutral at UBS with analyst Damian Karas saying the company is trading at a "peak multiple on peak growth." 4. Weibo (WB) downgraded to Reduce from Hold at HSBC. 5. Big Lots (BIG) downgraded to Neutral from Overweight at Piper Jaffray with analyst Peter Keith saying the downgrade is based on risk to first half of 2019 estimates as well as ongoing tariff concerns. This list is just a portion of The Fly's full analyst coverage...

Merrill on the "Softening" Auto Sector

A few brief excerpt from a Merrill Lynch research note on the auto sector: Autos: lot full In our view, the peak in auto sales is clear and we will likely see some softening going forward, but we do not expect a sharp drop. The labor market is still solid with a healthy pace of job growth and the emergence of wage inflation. Consumers are feeling increasingly confident about job prospects, which could encourage the purchase of a big-ticket item such as a vehicle. Absent a recession, auto sales will avoid the painful drop. The slowdown in sales leads to excess inventory ... the excess inventory is largely concentrated in light trucks and SUVs and the cost to carry such inventory is high. Producers have started to respond, with motor vehicle production down 2.5% mom sa in April, marking the second drop in three months. There is likely more to come. A weakening in the auto cycle will serve as a...

Kansas City Fed: "Growth in Tenth District Manufacturing Activity Continued at a Modest Pace"

The Federal Reserve Bank of Kansas City released the May Manufacturing Survey today. According to Chad Wilkerson, vice president and economist at the Federal Reserve Bank of Kansas City, the survey revealed that growth in Tenth District manufacturing activity continued at a modest pace, and expectations for future activity remained generally solid. “Regional factory growth was sluggish again in May,” said Wilkerson. “Several firms noted that new tariffs were disrupting activity.” The month-over-month composite index was 4 in May, similar to a reading of 5 in April but down from 10 in March. The composite index is an average of the production, new orders, employment, supplier delivery time, and raw materials inventory indexes. Growth continued to grow modestly at most durable and nondurable...

New Home Sales decreased to 673,000 Annual Rate in April, March Revised up to New Cycle High

The Census Bureau reports New Home Sales in April were at a seasonally adjusted annual rate (SAAR) of 692 thousand. The previous three months were revised up."Sales of new single‐family houses in April 2019 were at a seasonally adjusted annual rate of 673,000, according to estimates released jointly today by the U.S. Census Bureau and the Department of Housing and Urban Development. This is 6.9 percent below the revised March rate of 723,000, but is 7.0 percent above the April 2018 estimate of 629,000." The first graph shows New Home Sales vs. recessions since 1963. The dashed line is the current sales rate. Even with the increase in sales over the last several years, new home sales are still somewhat low historically. The second graph shows New Home Months of...

Chemical Activity Barometer Increased Slightly in May

From the American Chemistry Council: Chemical Activity Barometer Shows Third Monthly Gain in May. The Chemical Activity Barometer (CAB), a leading economic indicator created by the American Chemistry Council (ACC), rose 0.4 percent in May on a three-month moving average (3MMA) basis, the third monthly gain after several weak months. On a year-over-year (Y/Y) basis, the barometer is up 0.5 percent (3MMA). "Year-earlier comparisons have turned positive in recent months, and while trade tensions, slowing economic growth overseas, and soft economic reports in the U.S. have created uncertainty that has weighed on business investment, the CAB signals gains in U.S. commercial and industrial activity through mid-2019, albeit at a moderate pace,” said Kevin Swift, chief economist at ACC...

Comments on April Existing Home Sales

Earlier: NAR: Existing-Home Sales Decreased to 5.19 million in April A few key points: 1) The key for housing - and the overall economy - is new home sales, single family housing starts and overall residential investment. Overall, this is still a somewhat reasonable level for existing home sales. No worries. 2) Inventory is still low, and was only up 1.7% year-over-year (YoY) in April. This was the ninth consecutive month with a year-over-year increase in inventory, although the YoY increase was smaller in April than in the six previous months. 3) Year-to-date sales are down about 4.9% compared to the same period in 2018. On an annual basis, that would put sales around 5.1 million in 2019. Sales slumped at the end of and in January 2019 due to higher mortgage rates...

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. KKR (KKR) downgraded to Neutral from Outperform at Credit Suisse analyst Craig Siegenthaler citing a lower relative 12-month total return forecast and following the stock's 25%-30% total return year to date. 2. Ocular Therapeutix (OCUL) downgraded to Market Perform from Strong Buy at Raymond James and to Market Perform from Outperform at Cowen. 3. CAE (CAE) downgraded to Market Perform from Outperform at BMO Capital and to Hold from Buy citing "limited potential returns." 4. Tremont Mortgage Trust (TRMT) downgraded to Neutral from Buy at UBS with analyst Brock Vandervliet saying last week's surprising capital raise has eroded shareholder value. 5. Carlyle Group (CG) downgraded to Neutral from Outperform at Credit Suisse with analyst...

U.S. CBD market could grow to $15B in five years, says Piper Jaffray

The FDA's previous decision that red yeast rice is an acceptable dietary supplement with naturally occurring levels of Monacolin K may set precedent for full spectrum or broad spectrum hemp extract that contains cannabidiol, or CBD, Piper Jaffray analyst Michael Lavery tells investors in a research note. However, CBD is the active ingredient in FDA-approved Epidiolex, which complicates its regulatory treatment, the analyst adds. He notes that because CBD is in an approved drug, the FDA rules do not allow it to be marketed as a dietary supplement. Nonetheless, given the red yeast rice precedent, the analyst "would logically expect" the FDA to allow products with hemp extract to be marketed as over-the-counter dietary...

Recent Tweets @InvestChannel

Follow Us on Twitter